Bionoid Pharma, Inc. BINP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

14/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Bionoid Pharma, Inc. (BINP) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 12/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

14/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

14/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — BINP

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2009	$-0.16	$0.00	$-3.41M	-
2010	$-0.13	$0.00	$-3.91M	-
2011	$-335.25	$0.00	$-5.14M	-
2013	$-46.27	$92.00	$-1.62K	-1764.1%
2019	$0.70	$56.17K	$27.15K	48.3%
2020	$-11.88	$30.66K	$-455.78K	-1486.7%
2021	$0.00	$102.12K	$-135K	-132.2%
2022	$0.00	$36.04K	$1.48K	4.1%
2023	$0.00	$37.51K	$-7.81K	-20.8%
2024	$0.00	$0.00	$-317K	-